Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy (original) (raw)
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy
Filippo Alongi
Radiotherapy and Oncology, 2009
View PDFchevron_right
Does Treatment of the Pelvic Nodes with IMRT Increase Late Rectal Toxicity over Conformal Prostate-Only Radiotherapy to 76 Gy?
Vito Vitale
Strahlentherapie und Onkologie, 2006
View PDFchevron_right
Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patients
Chandana Reddy
Practical Radiation Oncology, 2013
View PDFchevron_right
Clinical Toxicities and Dosimetric Parameters after Whole-Pelvis versus Prostate Bed-only Intensity
Curtiland Deville
Fuel and Energy Abstracts, 2010
View PDFchevron_right
Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy
Barbara Longobardi
Radiotherapy and Oncology
View PDFchevron_right
Analysis of Gastrointestinal and Genitourinary Morbidity of Postoperative Radiotherapy for Pathologic T3 Disease or Positive Surgical Margins After Radical Prostatectomy Using National Cancer Institute Expanded Common Toxicity Criteria
Cyril Danjoux, Gerard Morton
International Journal of Radiation Oncology*Biology*Physics, 2008
View PDFchevron_right
PO-0821: Radiation-induced late rectal toxicity for IMPT vs VMAT in patients with localized prostate cancer
Charlotte Brouwer
Radiotherapy and Oncology, 2018
View PDFchevron_right
No increase in toxicity of pelvic irradiation when intensity modulation is employed: Clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy
Matteo Muto
The British Journal of Radiology, 2016
View PDFchevron_right
Clinical Toxicities and Dosimetric Parameters after Whole-Pelvis versus Prostate Bed-only Intensity Modulated Radiation Therapy for Prostate Cancer
Curtiland Deville
International Journal of Radiation Oncology*Biology*Physics, 2010
View PDFchevron_right
Late Toxicity After Intensity-Modulated Radiation Therapy for Localized Prostate Cancer: An Exploration of Dose–Volume Histogram Parameters to Limit Genitourinary and Gastrointestinal Toxicity
Stanley Liauw
International Journal of Radiation Oncology*Biology*Physics, 2012
View PDFchevron_right
The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer
Pin-i Huang, Kuan-Hsuan Chen
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy
Katrien Vandecasteele, Gert De Meerleer
Radiotherapy and Oncology, 2008
View PDFchevron_right
Clinical and Dosimetric Predictors of Late Rectal Syndrome After 3D-CRT for Localized Prostate Cancer: Preliminary Results of a Multicenter Prospective Study
Tiziana Rancati
International Journal of Radiation Oncology Biology Physics, 2008
View PDFchevron_right
Predictors for Rectal and Intestinal Acute Toxicities During Prostate Cancer High-Dose 3D-CRT: Results of a Prospective Multicenter Study
Michele Stasi
International Journal of Radiation Oncology Biology Physics, 2007
View PDFchevron_right
Comparative study between treatment related acute toxicity in patients receiving 3DCRT/IMRT as a definitive radiotherapy for localized prostatic carcinoma with assessment of quality of life in those patients
Shorouk badr
Onkologia i Radioterapia, 2020
View PDFchevron_right
Late rectal and bladder toxicity following radiation therapy for prostate cancer: Predictive factors and treatment results
Alvar Rosello Serrano, Rafael Fuentes-raspall, Jose M . Inoriza
Reports of Practical Oncology & Radiotherapy, 2013
View PDFchevron_right
P024 Late rectal toxicity after RT for prostate cancer: Case of patients with moderate/severe basal symptoms
Tiziana Rancati
European Urology Supplements, 2014
View PDFchevron_right
Exceptionally High Incidence of Grade 2-3 Late Rectal Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft Tissue-matched Image-guided Intensity-modulated Radiotherapy
Takuya Nishimura
Anticancer Research, 2013
View PDFchevron_right
Rectal balloon use limits vaginal displacement, rectal dose, and rectal toxicity in patients receiving IMRT for postoperative gynecological malignancies
Yen-Ruh Wuu
Medical Dosimetry, 2017
View PDFchevron_right
Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer
Etienne Martin
Radiation oncology (London, England), 2016
View PDFchevron_right
A Comparison of Acute and Chronic Toxicity for Men With Low-Risk Prostate Cancer Treated With Intensity-Modulated Radiation Therapy or 125I Permanent Implant
Thomas Eade
International Journal of Radiation Oncology*Biology*Physics, 2008
View PDFchevron_right
Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial
Jennifer johnson
International Journal of Radiation Oncology*Biology*Physics, 2014
View PDFchevron_right
Rectal dose reduction with IMRT for prostate radiotherapy.
Andrew Miller
View PDFchevron_right
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406
Carlos Perez
International Journal of Radiation Oncology Biology Physics, 2000
View PDFchevron_right
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Raffaele Liuzzi
Radiation Oncology, 2013
View PDFchevron_right